Azelastine Hydrochloride; Fluticasone Propionate Nasal Spray — FDA Drug Shortage

No longer listed by FDA — Mylan Pharmaceuticals Inc., A Viatris Company

The FDA lists a drug shortage record for Azelastine Hydrochloride; Fluticasone Propionate Nasal Spray (nasal spray) from Mylan Pharmaceuticals Inc., A Viatris Company with status No longer listed by FDA. The shortage was first posted on Sep 4, 2025.

Shortage details

Status
No longer listed by FDA
Company
Mylan Pharmaceuticals Inc., A Viatris Company
Package NDC
0378-3458-23
Dosage Form
Nasal Spray
Presentation
Azelastine Hydrochloride; Fluticasone Propionate, Nasal Spray, 137 ug; 50 ug (NDC 0378-3458-23)
Initial Posting
Sep 4, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.